PFPaulo Emílio Fuganti

Paulo Emílio Fuganti

*This is an algorithmically generated author record based on publicly available information.

Paulo Emílio Fuganti has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Genetic variants in 8-oxoguanine DNA glycosylase 1 ( OGG1 ) and X-ray repair cross-complementing protein 1 ( XRCC1 ) and non-genetic factors are associated with bladder cancer susceptibility and prognosis in a Brazilian population

    by Milene Roldão de Souza Rodrigues, Isabely Mayara da Silva, Beatriz Geovana Leite Vacario, Luíza Magosso Oliveira Rocha, Julia Ayumi Ikeda Kawasaki, Rebeca Eloi S. Porto, Paulo Emílio Fuganti, Alexsandro Koike, Mateus L. Falco, Roberta Losi Guembarovski, et al.

    Cellular responses to DNA damage play a crucial role in carcinogenesis, particularly in environmentally related cancers such as bladder cancer (BC). This is the ninth most frequently occurring cancer globally and most frequent in the urinary system. Polymorphic variants in genes encoding DNA repair proteins may interfere with their expression and/or activity. Consequently, modulation in an individual's gene response to exposure might occur resulting in greater susceptibility and lower survival rates in BC. Taking this into account, the study evaluated associations of single-nucleotide polymorphisms (SNPs) in base excision repair genes (XRCC1 rs25487 and OGG1 rs1052133) with BC susceptibility and prognosis. A total of 274 cases and 274 controls, matched on gender, age, and smoking status, were genotyped using DNA from peripheral blood. In susceptibility analyses, individuals with a family history of cancer who carried at least one reference allele (rs1052133, CC + CG) exhibited an increased risk of BC occurrence. For XRCC1, the TT + CC genotypes were associated with elevated risk for BC among pesticide-exposed individuals. Regarding prognosis, the rs1052133 CC genotype was associated with an enhanced risk of recurrence among smokers and female patients. Bioinformatic analyses indicated significantly higher expression of XRCC1 and OGG1 in bladder tissue and marked elevation in expression in tumors. These results suggest that gene-environment interaction might modulate risk of BC occurrence and subsequent prognosis.

  • Genetic polymorphisms, methylation, and expression levels in the GSTP1 and MGMT genes in urothelial bladder tumors

    by Juliana Mara Serpeloni, Isabely Mayara da Silva, André van Helvoort Lengert, Marilesia Ferreira de Souza, Mariana Bisarro dos Reis, Hellen Kuasne, Paulo Emílio Fuganti, Ilce Mara de Syllos Cólus

  • Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management

    by Isabely Mayara da Silva, Beatriz Geovana Leite Vacario, Nádia Calvo Martins Okuyama, Gustavo Rafael Mazzaron Barcelos, Paulo Emílio Fuganti, Roberta Losi Guembarovski, Ilce Mara de Syllos Cólus, Juliana Mara Serpeloni


  • Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis

    by Marilesia Ferreira de Souza, Monyse de Nóbrega, Heloísa Lizotti Cilião, Mariana Bisarro dos Reis, Paulo Emílio Fuganti, Ilce Mara de Syllos Cólus

    Background There is an ongoing search for molecular markers that are specific, sensitive, and able to predict the stage of prostate cancer (PCa), which is the second most prevalent type of cancer in men worldwide. This study examined whether different single nucleotide polymorphisms (SNPs) were reliable markers of susceptibility to and prognosis of PCa in a sample of Brazilian patients. Methods and results DNA samples were extracted from peripheral blood cells of 283 PCa patients and matched with samples from healthy controls. Single nucleotide polymorphisms (SNPs in four genes (BCL-2–rs2279115, CASP3–rs4647603, CASP9–rs1052571, and NKX3-1–rs11781886) were genotyped by real-time PCR using the TaqMan® probe. Odds Ratios with 95% confidence intervals were calculated for allelic and genotypic frequencies. The association between polymorphic variants, risk of developing PCa, and clinicopathological characteristics was analyzed by univariate and multivariate logistic regression analysis. SNPs in CASP3, CASP9, and NKX3-1 genes, either alone or in combination (BCL-2+NKX3-1 and CASP3+NKX3-1) were associated with the risk of developing PCa. Genotypes and tumor histopathological data indicated that the BCL-2, NKX3-1, and CASP3 allelic variants, either alone or combined in pairs, were associated with a poor prognosis of PCa. Conclusions Genetic polymorphisms in CASP3, NKX3-1, and BCL-2 genes were associated with susceptibility to PCa. The SNPs in the three genes alone and the SNP in the BCL-2 gene combined with the other two genes were strongly associated with adverse outcomes in PCa patients and are promising candidates for molecular markers for PCa prognosis.


  • Open Access

    Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer

    by Monyse De Nóbrega, Heloisa Lizotti Cilião, Marilesia Ferreira De Souza, Milene Roldão De Souza, Juliana Mara Serpeloni, Paulo Emilio Fuganti, Ilce Mara De Syllos Cólus

    Polymorphic variants in the PTEN (rs2735343), PI3K (rs2699887), AKT1 (rs2494750), AR (rs17302090), and AMACR (rs3195676) genes were evaluated as possible molecular markers of susceptibility, prognosis, and progression of prostate cancer (PCa), in a case-control study. Samples consisted of 277 patients with PCa and 277 controls from Londrina, PR, Brazil. SNPs were analyzed by real-time PCR. A family history of cancer, including PCa, as well as level of schooling were risk factors for PCa. The data were obtained via logistic regression, using odds ratios with a CI 95%. The genotypes of AKT1 and AKT1+AR demonstrated an association with protection for the disease. The combination of SNPs with the histopathological tumor data between allele variants of AMACR, AKT1+AR, and AKT1+AMACR indicated an association with protection against seminal vesicle invasion. The polymorphisms AKT1+AR and PI3K+AR were associated with protection against tumor bilaterality. The genotype combinations PTEN+AMACR and PTEN+AR were associated with the risk of extracapsular extension. Of the five genes studied, two were associated with protection for PCa, four were associated with protection for some prognostic variables, and only one was associated with risk. Thus, these SNPs are candidates for markers to discriminate men with better or worse prognosis for PCa.